NeueHealth (NYSE:NEUE) Director Rick Yang Sells 3,635 Shares

NeueHealth, Inc. (NYSE:NEUE) Director Rick Yang sold 3,635 shares of the firm’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $6.75, for a total value of $24,536.25. Following the sale, the director directly owned 488,702 shares of the company’s stock, valued at approximately $3,298,738.50. This represents a 0.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

NeueHealth Price Performance

Shares of NYSE:NEUE opened at $6.75 on Tuesday. The firm has a market capitalization of $60.94 million, a PE ratio of -0.42 and a beta of 0.59. The company has a 50-day moving average price of $6.72 and a two-hundred day moving average price of $6.73. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66.

NeueHealth (NYSE:NEUE) last released its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping the consensus estimate of ($4.77) by $3.09. The business had revenue of $209.08 million during the quarter, compared to the consensus estimate of $249.50 million. Analysts anticipate that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of NeueHealth in a research report on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $7.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. bought a new stake in NeueHealth, Inc. (NYSE:NEUE) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 29,115 shares of the company’s stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned about 0.33% of NeueHealth at the end of the most recent quarter. Institutional investors own 63.88% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.